Skip to content

Self-modulation of the Sense of Agency by Means of Real-time Neurofeedback

Self-modulation of the Sense of Agency by Means of Real-time Neurofeedback

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05214833
Acronym
NF-Agency
Enrollment
225
Registered
2022-01-31
Start date
2022-02-01
Completion date
2025-01-31
Last updated
2022-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Psychogenic Seizure, Epilepsy, Temporal Lobe, Health, Subjective

Keywords

sense of agency

Brief summary

This study investigates whether the sense of agency is sensitive to self-regulation by means of EEG-based neurofeedback. During neurofeedback, the brain activity in response to a motor task is recorded in real-time and displayed back to the participants. The participants can therefore use this information to adapt their performance on the motor task.

Interventions

During neurofeedback, the brain activity in response to a motor task is recorded in real-time and displayed back to the participants.

During sham neurofeedback, a signal which resembles the participant's brain activity is used instead of the actual brain activity.

Sponsors

Swiss Epilepsy Centre - Klinik Lengg
CollaboratorUNKNOWN
ETH Zurich
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
DOUBLE (Subject, Investigator)

Intervention model description

Two arms will be investigated. The first one will receive real neurofeedback. The second one will receive sham neurofeedback (comparator). During sham neurofeedback, a signal which resembles the participant's brain activity is used instead of the actual brain activity.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

(all): * Aged \> 18 years old * Normal or corrected-to-normal visual acuity * Willing to participate in the study (by signing the informed consent form) * Neither caffein, nor alcohol intake 48 hours prior to the experiment * Regular intake of drugs (except oral contraceptives in women) * Employed by, or in a dependent relationship with, the sponsor and / or the investigator(s) * Sufficient knowledge of German or English to understand study documents and instructions. Inclusion Criteria (patients): * A diagnosis of temporal epilepsy (TE), documented via video EEG. OR * A diagnosis of psychogenic non-epileptic seizure (PNES), according to the Diagnostic and Statistical Manual of Mental Disorders (DSM-5), and documented via video EEG.

Exclusion criteria

(all): * Past surgery in the brain * History of alcohol or drug abuse * Incompatibility with EEG recordings, e.g., inability to stay seated for 90 minutes.

Design outcomes

Primary

MeasureTime frameDescription
Change in Electrophysiological data, i.e., EEG power in alpha bandBefore and immediately after neurofeedbackBrain activity
Change in Electrophysiological data, i.e., EEG power in theta bandBefore and immediately after neurofeedbackBrain activity
Change in Electrophysiological data, i.e., EEG power in gamma bandBefore and immediately after neurofeedbackBrain activity
Change in the subjective perception of the Sense of Agency, i.e., visual analog scale assessing how much control participants feel over the gameBefore and immediately after neurofeedbackBehavioural performance in response to manipulation of the Sense of Agency (SoA)

Other

MeasureTime frameDescription
AnxietyBefore neurofeedbackBaseline variable assessed with the State-Trait Anxiety Inventory (STAI). Minimum value (20) = no anxiety. Maximum value (80) = high anxiety.
MoodBefore neurofeedbackBaseline variable assessed with a visual analog scale. Minimum value (0) = bad mood. Maximum value (100) = good mood.
Age in yearsBefore neurofeedbackBaseline variable
Daily rate of cigarettesBefore neurofeedbackBaseline variable assessed in number of cigarettes/day
Sleep habitsBefore neurofeedbackBaseline variable assessed with the Pittsburgh Sleep Quality Index (PSQI). Minimum value (0) = good sleep quality. Maximum value (20) = poor sleep quality.
Sex (male/female)Before neurofeedbackBaseline variable
Years of educationBefore neurofeedbackBaseline variable
Medication statusBefore neurofeedbackBaseline variable, list of drugs currently in use by the participant

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026